Ascentage Pharma director discloses equity awards

Q: What does the AAPG Form 3 filed by Debra Yu show?

The Form 3 shows director Debra Yu reporting initial holdings of stock options and restricted stock units in Ascentage Pharma Group International, detailing the number of underlying Ordinary Shares, exercise price, and vesting schedules for these equity awards.

Q: How many AAPG Ordinary Shares underlie Debra Yu’s stock options?

Debra Yu’s stock options are linked to 53,895 Ordinary Shares. These options carry an exercise price of $8.14 per share, expire on 11/26/2035, and vest in four equal annual increments beginning on 11/26/2026.

Q: What are the terms of Debra Yu’s restricted stock units in AAPG?

She holds RSUs covering 63,895 Ordinary Shares. Each RSU converts into one Ordinary Share upon vesting, with vesting in four equal annual installments on 11/26/2026, 2027, 2028 and 2029, and the RSUs have no expiration date.

Q: When do Debra Yu’s AAPG stock options and RSUs vest?

Both the stock options and RSUs vest in four equal annual increments on 11/26/2026, 11/26/2027, 11/26/2028 and 11/26/2029. This schedule spreads her potential ownership and alignment with the company’s performance over several years.

Q: What is the exercise price of Debra Yu’s AAPG stock options?

The stock options have an exercise price of $8.14 per share. The price is originally denominated in HKD, with the disclosed figure representing a conversion to USD based on the exchange rate on the grant date.

Q: Do Debra Yu’s AAPG restricted stock units have an expiration date?

Her restricted stock units have no expiration date. They convert into Ordinary Shares only upon vesting, which occurs in four equal annual installments from 11/26/2026 through 11/26/2029, as long as the applicable vesting conditions are satisfied.

ASCENTAGE PHARMA GROUP INTERNATIONAL director Debra Yu filed an initial Form 3 showing equity awards in the company.

Accepted by SEC EDGAR 03/19/2026 - 11:14 AM EDT

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

ASCENTAGE PHARMA GROUP INTERNATIONAL director Debra Yu filed an initial Form 3 showing equity awards in the company. She holds stock options linked to 53,895 Ordinary Shares with an exercise price of $8.14 per share, expiring on 11/26/2035, vesting in four equal annual increments from 11/26/2026 through 2029.

She also holds restricted stock units covering 63,895 Ordinary Shares. Each RSU represents the right to receive one Ordinary Share upon vesting. These RSUs vest in four equal annual installments on 11/26/2026, 2027, 2028 and 2029 and have no expiration date.

Insider Trade Summary

Holdings reported, no transactions

Holdings

Insider Yu Debra

Role Director

Type	Security	Shares	Price	Value
Holding	Options	--	--	--
Holding	Restricted stock units	--	--	--

Holdings: Options — 53,895 contracts (Direct); Restricted stock units — 63,895 contracts (Direct)

Footnotes (3)

F1. The stock options vest in four equal increments on each of 11/26/2026, 2027, 2028 and 2029.
F2. The exercise price for the stock options is in HKD, and the exercise price included in the table represents conversion to USD based on the exchange rate on the date of grant.
F3. Each restricted stock unit (RSUs) represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on each of 11/26/2026, 2027, 2028 and 2029 and have no expiration date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the AAPG Form 3 filed by Debra Yu show?

The Form 3 shows director Debra Yu reporting initial holdings of stock options and restricted stock units in Ascentage Pharma Group International, detailing the number of underlying Ordinary Shares, exercise price, and vesting schedules for these equity awards.

How many AAPG Ordinary Shares underlie Debra Yu’s stock options?

Debra Yu’s stock options are linked to 53,895 Ordinary Shares. These options carry an exercise price of $8.14 per share, expire on 11/26/2035, and vest in four equal annual increments beginning on 11/26/2026.

What are the terms of Debra Yu’s restricted stock units in AAPG?

She holds RSUs covering 63,895 Ordinary Shares. Each RSU converts into one Ordinary Share upon vesting, with vesting in four equal annual installments on 11/26/2026, 2027, 2028 and 2029, and the RSUs have no expiration date.

When do Debra Yu’s AAPG stock options and RSUs vest?

Both the stock options and RSUs vest in four equal annual increments on 11/26/2026, 11/26/2027, 11/26/2028 and 11/26/2029. This schedule spreads her potential ownership and alignment with the company’s performance over several years.

What is the exercise price of Debra Yu’s AAPG stock options?

The stock options have an exercise price of $8.14 per share. The price is originally denominated in HKD, with the disclosed figure representing a conversion to USD based on the exchange rate on the grant date.

Do Debra Yu’s AAPG restricted stock units have an expiration date?

Her restricted stock units have no expiration date. They convert into Ordinary Shares only upon vesting, which occurs in four equal annual installments from 11/26/2026 through 11/26/2029, as long as the applicable vesting conditions are satisfied.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Yu Debra

(Last)

(First)

(Middle)

700 KING FARM BLVD

STE 510

(Street)

ROCKVILLE

MARYLAND

20850

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
ASCENTAGE PHARMA GROUP INTERNATIONAL [ AAPG ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Options	⁽¹⁾	11/26/2035	Ordinary Shares	53,895	$8.14⁽²⁾	D
Restricted stock units	⁽³⁾	⁽³⁾	Ordinary Shares	63,895	$0	D

Explanation of Responses:

1. The stock options vest in four equal increments on each of 11/26/2026, 2027, 2028 and 2029.

2. The exercise price for the stock options is in HKD, and the exercise price included in the table represents conversion to USD based on the exchange rate on the date of grant.

3. Each restricted stock unit (RSUs) represents a contingent right to receive one Ordinary Share of the Issuer upon vesting. The RSUs vest in four equal increments on each of 11/26/2026, 2027, 2028 and 2029 and have no expiration date.

Remarks:

	Debra Yu	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR